Education
About Us
Working with TipRanks
Follow Us
ECNS - ETF AI Analysis
Top Page
iShares MSCI China Small-Cap ETF (ECNS)
Rating:55Neutral
Price Target:―
Positive Factors
Strong Sector Focus
The ETF has significant exposure to high-growth sectors like Health Care and Technology, which can drive long-term returns.
Diversified Holdings
The fund includes a wide range of small-cap companies across multiple industries, reducing reliance on any single sector.
Improving Year-to-Date Performance
The ETF has shown positive year-to-date performance, indicating recovery and potential growth momentum.
Negative Factors
High Geographic Concentration
Nearly 90% of the ETF's exposure is in Hong Kong, making it vulnerable to regional economic and political risks.
Mixed Top Holdings Performance
Some top holdings have underperformed year-to-date, which could weigh on overall fund performance.
Relatively High Expense Ratio
The ETF charges a higher expense ratio compared to many other funds, which could eat into investor returns over time.
ECNS vs. SPDR S&P 500 ETF (SPY)
AUM99.83M
RegionAsia-Pacific
Expense Ratio0.59%
Beta0.69
IssueriShares
Inception DateSep 28, 2010
Dividend Yield4.62%
Asset ClassEquity
Index TrackedMSCI China Small Cap
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume33,732
30 Day Avg. Volume51,942
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
46.33Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering242
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
ECNS Summary
The iShares MSCI China Small-Cap ETF (ECNS) is an investment fund that focuses on small companies in China, offering exposure to the country’s fast-growing economy. It tracks the MSCI China Small Cap Index and includes innovative businesses like Zai Lab Ltd and China Gold International Resources. This ETF is ideal for investors looking to diversify their portfolio and potentially benefit from the growth of smaller, entrepreneurial firms in China. However, it’s important to know that small-cap stocks can be more volatile, meaning their prices can rise and fall quickly, which adds risk to your investment.
How much will it cost me?The iShares MSCI China Small-Cap ETF (ECNS) has an expense ratio of 0.59%, which means you’ll pay $5.90 per year for every $1,000 invested. This is higher than average because the fund is actively managed to focus on small-cap stocks in China, which requires more research and management compared to passively managed funds. It’s designed for investors seeking growth opportunities in a niche market.
What would affect this ETF?The iShares MSCI China Small-Cap ETF (ECNS) could benefit from China's economic growth and government support for innovation, especially in sectors like healthcare and technology, which make up a significant portion of its holdings. However, risks include potential regulatory changes in China, global economic uncertainty, and the volatility of small-cap stocks, which are more sensitive to market fluctuations. Investors should also consider how geopolitical tensions or shifts in trade policies might impact the ETF's performance.
ECNS Top 10 Holdings
The ECNS ETF is heavily tilted toward China's health care and industrial sectors, with small-cap stocks driving its focus on innovation and growth. While names like China Gold International Resources and China Nonferrous Mining Corp. are rising steadily, contributing positively to the fund’s performance, others like Zai Lab Ltd and Ascentage Pharma are lagging, weighed down by bearish momentum and financial challenges. The fund’s concentration in China’s small-cap market offers exposure to entrepreneurial ventures, but mixed stock performance highlights the risks inherent in this niche strategy.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| China Gold International Resources | 2.41% | $2.45M | HK$55.68B | 268.40% | ― | |
| Minth Group | 1.84% | $1.87M | HK$39.77B | 160.36% | 71 Outperform | |
| XD, Inc. | 1.47% | $1.49M | HK$34.26B | 168.05% | 61 Neutral | |
| China Nonferrous Mining Corp. Ltd. | 1.35% | $1.38M | HK$54.51B | 151.24% | 76 Outperform | |
| China Everbright | 1.33% | $1.35M | HK$30.10B | 44.16% | 66 Neutral | |
| Ascentage Pharma Group International | 1.19% | $1.21M | HK$23.13B | 48.44% | 45 Neutral | |
| China Medical System Holdings | 1.15% | $1.17M | HK$32.57B | 40.33% | 65 Neutral | |
| Zai Lab Ltd | 1.13% | $1.15M | HK$17.12B | -32.42% | 40 Underperform | |
| Kingboard Holdings | 1.13% | $1.15M | HK$28.68B | 44.68% | 69 Neutral | |
| RemeGen Co. Ltd. Class H | 1.13% | $1.15M | HK$50.59B | 377.08% | 40 Underperform |
ECNS Technical Analysis
Negative
―
Price Trends
37.15
Negative
36.69
Negative
32.37
Positive
Market Momentum
-0.58
Positive
41.56
Neutral
31.40
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For ECNS, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 35.80, equal to the 50-day MA of 37.15, and equal to the 200-day MA of 32.37, indicating a neutral trend. The MACD of -0.58 indicates Positive momentum. The RSI at 41.56 is Neutral, neither overbought nor oversold. The STOCH value of 31.40 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ECNS.
ECNS Peer Comparison
Comparison Results
Performance Comparison
ECNS
iShares MSCI China Small-Cap ETF
35.19
10.71
43.75%
MCHI
iShares MSCI China ETF
―
―
―
FXI
iShares China Large-Cap ETF
―
―
―
FLCH
Franklin FTSE China ETF
―
―
―
PGJ
Invesco Golden Dragon China Etf
―
―
―
FCA
First Trust China AlphaDEX Fund
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents